A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Table of Contents
Market Analysis: IVD Overview
Overview of IVD
Market Outlook
COVID-19 Impact
Major Product Activity
Company Briefs
Abbott Diagnostics
Roche
Danaher
Regional Market
Executive News Briefing
Chembio Diagnostics Receives $3.2 Million Contract Award
Rarecells Appoints New Director to the Board
Gemina Labs Appoints New CEO
Cue Health Exceeds Performance Estimates, Increasing 32% in H1 2022
Myriad Genetics Reports Gains in Pharmacogenomics, Prenatal Test Screening and Tumor Profiling in Q2’22
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
Partnerships and Collaborations
Industry Watch
COVID-19 Update
Region Watch
Argentina
Malaysia
Slovakia
Broad-based Company Announcements
Biocartis Group Launches SkylineDx’s Merlin Assay in Europe
Outsourcing drug discovery is the beginning phase of the drug development process. Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can…